Proteolytic Activity-Independent Activation of the Immune Response by Gingipains from Porphyromonas gingivalis.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
28 06 2022
Historique:
pubmed: 3 5 2022
medline: 1 7 2022
entrez: 2 5 2022
Statut: ppublish

Résumé

Porphyromonas gingivalis, a keystone pathogen in periodontitis (PD), produces cysteine proteases named gingipains (RgpA, RgpB, and Kgp), which strongly affect the host immune system. The range of action of gingipains is extended by their release as components of outer membrane vesicles, which efficiently diffuse into surrounding gingival tissues. However, away from the anaerobic environment of periodontal pockets, increased oxygen levels lead to oxidation of the catalytic cysteine residues of gingipains, inactivating their proteolytic activity. In this context, the influence of catalytically inactive gingipains on periodontal tissues is of significant interest. Here, we show that proteolytically inactive RgpA induced a proinflammatory response in both gingival keratinocytes and dendritic cells. Inactive RgpA is bound to the cell surface of gingival keratinocytes in the region of lipid rafts, and using affinity chromatography, we identified RgpA-interacting proteins, including epidermal growth factor receptor (EGFR). Next, we showed that EGFR interaction with inactive RgpA stimulated the expression of inflammatory cytokines. The response was mediated via the EGFR-phosphatidylinositol 3-kinase (PI3K)-protein kinase B (AKT) signaling pathway, which when activated in the gingival tissue rich in dendritic cells in the proximity of the alveolar bone, may significantly contribute to bone resorption and the progress of PD. Taken together, these findings broaden our understanding of the biological role of gingipains, which in acting as proinflammatory factors in the gingival tissue, create a favorable milieu for the growth of inflammophilic pathobionts.

Identifiants

pubmed: 35491845
doi: 10.1128/mbio.03787-21
pmc: PMC9239244
doi:

Substances chimiques

Adhesins, Bacterial 0
Gingipain Cysteine Endopeptidases 0
ErbB Receptors EC 2.7.10.1
Cysteine Endopeptidases EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0378721

Subventions

Organisme : NIDCR NIH HHS
ID : R01 DE030939
Pays : United States
Organisme : NIDCR NIH HHS
ID : R37 DE011111
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE022597
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE011111
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE012505
Pays : United States

Références

Periodontol 2000. 2010 Oct;54(1):15-44
pubmed: 20712631
Infect Immun. 2009 Mar;77(3):1246-61
pubmed: 19114547
BMC Microbiol. 2015 Oct 05;15:197
pubmed: 26438063
Infect Immun. 2001 Aug;69(8):5121-30
pubmed: 11447194
J Cell Sci. 2019 Dec 5;133(5):
pubmed: 31722981
Mol Pharmacol. 2004 Dec;66(6):1599-606
pubmed: 15361547
Curr Protoc Protein Sci. 2007 Aug;Chapter 21:Unit 21.20
pubmed: 18429320
Cancers (Basel). 2017 May 17;9(5):
pubmed: 28513565
Mol Microbiol. 2017 Oct;106(1):35-53
pubmed: 28714554
J Cell Biol. 2003 Sep 29;162(7):1189-96
pubmed: 14517202
Future Microbiol. 2015;10(9):1517-27
pubmed: 26343879
Infect Immun. 2002 May;70(5):2512-8
pubmed: 11953390
Front Microbiol. 2020 Apr 28;11:722
pubmed: 32411104
Mol Oral Microbiol. 2016 Oct;31(5):365-78
pubmed: 26466922
mBio. 2021 Jun 29;12(3):e0050221
pubmed: 34182783
J Clin Periodontol. 2005 Apr;32(4):383-9
pubmed: 15811056
Sci Rep. 2016 Sep 22;6:33949
pubmed: 27653775
J Periodontol. 2005 Nov;76(11 Suppl):2106-15
pubmed: 16277583
Oral Microbiol Immunol. 2004 Apr;19(2):88-94
pubmed: 14871347
J Cell Mol Med. 2005 Jan-Mar;9(1):59-71
pubmed: 15784165
FEBS Lett. 1998 Sep 11;435(1):45-8
pubmed: 9755856
Sci Adv. 2019 Jan 23;5(1):eaau3333
pubmed: 30746447
Periodontol 2000. 2021 Jun;86(1):210-230
pubmed: 33690950
BMC Microbiol. 2008 Feb 06;8:26
pubmed: 18254977
Proteomics. 2007 Dec;7(23):4323-37
pubmed: 17979175
Infect Immun. 2004 Jul;72(7):3743-51
pubmed: 15213114
Infect Immun. 2011 Feb;79(2):797-805
pubmed: 21098107
Cell Death Dis. 2017 Mar 2;8(3):e2644
pubmed: 28252646
BMC Microbiol. 2009 May 27;9:107
pubmed: 19473524
PLoS One. 2013 Jul 23;8(7):e70199
pubmed: 23894616
PLoS Pathog. 2019 May 20;15(5):e1007773
pubmed: 31107907
Periodontol 2000. 2020 Jun;83(1):14-25
pubmed: 32385883
Biol Chem. 2015 Apr;396(4):377-84
pubmed: 25720118
J Periodontal Res. 2013 Dec;48(6):713-21
pubmed: 23441958
Cell Tissue Res. 2014 Sep;357(3):633-43
pubmed: 24850273
J Innate Immun. 2009;1(2):109-17
pubmed: 20375569
Front Cell Infect Microbiol. 2017 May 26;7:215
pubmed: 28603700
J Oral Microbiol. 2014 Aug 18;6:
pubmed: 25206939
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Innate Immun. 2015;7(2):127-135
pubmed: 25228314
EMBO J. 2006 Mar 8;25(5):1024-34
pubmed: 16482216
BMC Microbiol. 2013 Jul 10;13:155
pubmed: 23841502
Infect Immun. 2013 Jan;81(1):55-64
pubmed: 23090954
Front Cell Infect Microbiol. 2017 Apr 27;7:140
pubmed: 28497028
Nat Rev Drug Discov. 2004 Jul;3(7):549-50
pubmed: 15272498
Eur J Microbiol Immunol (Bp). 2011 Mar;1(1):41-58
pubmed: 24466435
Mol Oral Microbiol. 2014 Dec;29(6):248-57
pubmed: 24976068
J Biol Chem. 2015 Feb 20;290(8):5190-5202
pubmed: 25564612
PLoS One. 2008 Jan 09;3(1):e1409
pubmed: 18183290
Nat Rev Genet. 2006 Aug;7(8):606-19
pubmed: 16847462
J Cell Physiol. 2011 Sep;226(9):2316-28
pubmed: 21660955

Auteurs

Izabela Ciaston (I)

Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian Universitygrid.5522.0, Krakow, Poland.

Joanna Budziaszek (J)

Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian Universitygrid.5522.0, Krakow, Poland.

Dorota Satala (D)

Department of Comparative Biochemistry and Bioanalytic, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian Universitygrid.5522.0, Krakow, Poland.

Barbara Potempa (B)

Department of Oral Immunity and Infectious Diseases, University of Louisvillegrid.266623.5 School of Dentistry, University of Louisville, Louisville, Kentucky, USA.

Andrew Fuchs (A)

Department of Oral Immunity and Infectious Diseases, University of Louisvillegrid.266623.5 School of Dentistry, University of Louisville, Louisville, Kentucky, USA.

Maria Rapala-Kozik (M)

Department of Comparative Biochemistry and Bioanalytic, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian Universitygrid.5522.0, Krakow, Poland.

Danuta Mizgalska (D)

Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian Universitygrid.5522.0, Krakow, Poland.

Ewelina Dobosz (E)

Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian Universitygrid.5522.0, Krakow, Poland.

Richard J Lamont (RJ)

Department of Oral Immunity and Infectious Diseases, University of Louisvillegrid.266623.5 School of Dentistry, University of Louisville, Louisville, Kentucky, USA.

Jan Potempa (J)

Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian Universitygrid.5522.0, Krakow, Poland.
Department of Oral Immunity and Infectious Diseases, University of Louisvillegrid.266623.5 School of Dentistry, University of Louisville, Louisville, Kentucky, USA.

Joanna Koziel (J)

Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian Universitygrid.5522.0, Krakow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH